Articles in IPOs

Renaissance Capital

Globant prices IPO at $10, below the range

Globant, an Argentina based IT outsourcer focused on mobile, cloud and big data, raised $59 million by offering 5.9 million shares at $10.00, below the range of $11.00 to $13.00. Globant plans... Read >>

Renaissance Capital

TubeMogul prices IPO at $7, low end of the revised range

TubeMogul, which provides a programmatic digital video ad buying platform for brand advertisers, raised $44 million by offering 6.3 million shares at $7, the low end of the revised range of $7... Read >>

Renaissance Capital

Epilepsy biotech Marinus Pharmaceuticals sets terms for $52 million IPO

Marinus Pharmaceuticals, a clinical stage biotech developing an add on therapy for adults with epilepsy, announced terms for its IPO on Friday. The New Haven, CT based company plans to raise $52... Read >>

Renaissance Capital

Trupanion prices IPO at $10, well below the range

Trupanion, which provides medical insurance covering cats and dogs in North America, raised $71 million by offering 7.1 million shares at $10, well below its $13 to $15 range. Trupanion will on... Read >>

Renaissance Capital

Blackstone-backed Catalent sets terms for $871 million IPO

Catalent, a global provider of oral, injectable and respiratory drug delivery technologies, announced terms for its IPO on Friday. The Somerset, NJ based company plans to raise $871 million by... Read >>

Renaissance Capital

TerraForm Power prices IPO at $25, high end of the revised range

TerraForm Power, a spinoff of SunEdison that owns contracted solar generation assets, raised $502 million by offering 20.1 million shares at $25, the high end of the revised range of $23 to $25.... Read >>

Renaissance Capital

TerraForm Power prices IPO at $25, high end of the revised range

TerraForm Power, a spinoff of SunEdison that owns contracted solar generation assets, raised $502 million by offering 20.1 million shares at $25, the high end of the revised range of $23 to $25.... Read >>

Renaissance Capital

Blank check company Terrapin 3 Acquisition prices IPO at $10

Terrapin 3 Acquisition, a blank check company backed by Terrapin Partners and led by Nathan Leight, raised $185 million by offering 18.5 million units at $10, as expected. Terrapin 3 Acquisition... Read >>

Renaissance Capital

Biotech Pfenex slashes proposed range to $8, adds shares

Pfenex, which is developing a biosimilar version of Roche's Lucentis treatment for wet AMD, lowered the proposed price range for its upcoming listing on Thursday. The San Diego, CA based company... Read >>

Renaissance Capital

TubeMogul cuts IPO price range by 38%; adds more insider buying (53% of deal)

TubeMogul, which provides a programmatic digital video ad buying platform for brand advertisers, lowered the proposed range for its upcoming IPO on Thursday and included additional insider... Read >>

Displaying 71-80 of 2551
<< first 8 9 10 11 12 50 100 150 200 250 last >>